Literature DB >> 7355670

Plasmalogenase and phospholipase A1, A2, and L1 activities in white matter in canine distemper virus-associated demyelinating encephalomyelitis.

S C Fu, R Mozzi, S Krakowka, R J Higgins, L A Horrocks.   

Abstract

Three weeks after inoculation of 24-day-old gnotobiotic dogs with Snyder-Hill canine distemper virus, white matter samples were taken from the primary predilection sites for canine distemper virus-associated demyelination. The plasmalogenase activity in extracts was nearly 6-fold greater than control values for a dog with extensive demyelination and was not detectable in tissue from a dog with non-demyelinating lesions. Acid and neutral phospholipases A1 and A2 were assayed in homogenates and extracts with phosphatidyl ethanolamine substrates. Phospholipase A2 activities at both pH 4.3 and pH 6.8 were less in the dog with severe demyelinating lesions than in dogs with less severe lesions. Phospholipase A1 activities were generally similar for all four dogs. The marked elevation of plasmalogenase activity in demyelinating tissue may be associated with a release from the plasmalogens of arachidonic acid which is converted to oxygenated metabolites that may then be responsible for the inflammation. Phospholipases acting on phosphatidyl ethanolamine do not seem to be involved in the pathogenesis of demyelination associated with canine distemper virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7355670     DOI: 10.1007/bf00692214

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

Review 1.  Animal model of human disease: subacute sclerosing panencephalitis, multiple sclerosis; animal model: distemper-associated demyelinating encephalomyelitis.

Authors:  A Koestner
Journal:  Am J Pathol       Date:  1975-02       Impact factor: 4.307

2.  Kinetic properties of plasmalogenase from bovine brain.

Authors:  R A D'Amato; L A Horrocks; K E Richardson
Journal:  J Neurochem       Date:  1975-06       Impact factor: 5.372

3.  Positional specificites in phospholipid hydrolyses.

Authors:  A F ROBERTSON; W E LANDS
Journal:  Biochemistry       Date:  1962-09       Impact factor: 3.162

4.  The structure of the naturally occurring phosphoglycerides. III. Action of moccasin-venom phospholipase A on ovolecithin and related substances.

Authors:  C LONG; I F PENNY
Journal:  Biochem J       Date:  1957-02       Impact factor: 3.857

5.  Simultaneous isolation of purified microsomal and myelin fractions from rat spinal cord.

Authors:  A D Toews; L A Horrocks; J S King
Journal:  J Neurochem       Date:  1976-07       Impact factor: 5.372

6.  Enzyme activities associated with the demyelinating phase of canine distemper. I. Beta-glucuronidase, acid and neutral proteinases.

Authors:  D N McMartin; A Koestner; J F Long
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

7.  Plasmalogenase activity in normal and demyelinating tissue of the central nervous system.

Authors:  G B Ansell; S Spanner
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

8.  Plasmalogenase activities in neuronal perikarya, astroglia, and oligodendroglia isolated from bovine brain.

Authors:  R V Dorman; A D Toews; L A Horrocks
Journal:  J Lipid Res       Date:  1977-01       Impact factor: 5.922

9.  The formation of lysophosphatides from di-acyl phosphatides by brain preparations.

Authors:  J GALLAI-HATCHARD; W L MAGEE; R H THOMPSON; G R WEBSTER
Journal:  J Neurochem       Date:  1962 Nov-Dec       Impact factor: 5.372

10.  Plasmalogenase is elevated in early demyelinating lesions.

Authors:  L A Horrocks; S Spanner; R Mozzi; S C Fu; R A D'Amato; S Krakowka
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

View more
  6 in total

1.  Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis.

Authors:  S J Huterer; W W Tourtellotte; J R Wherrett
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

Review 2.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

3.  Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.

Authors:  Suzanne M de la Monte; Jared Kay; Emine B Yalcin; Jillian J Kril; Donna Sheedy; Greg T Sutherland
Journal:  Alcohol       Date:  2017-08-17       Impact factor: 2.405

4.  The role of phospholipases from inflammatory macrophages in demyelination.

Authors:  J Trotter; M E Smith
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

5.  The effect of CMP on the release of free fatty acids of rat brain in vitro.

Authors:  G Goracci; E Francescangeli; L A Horrocks; G Porcellati
Journal:  Neurochem Res       Date:  1983-08       Impact factor: 3.996

6.  Biochemical changes in Cuprizone-induced spongiform encephalopathy. I. Changes in the activities of 2',3'-cyclic nucleotide 3'-phosphohydrolase, oligodendroglial ceramide galactosyl transferase, and the hydrolysis of the alkenyl group of alkenyl, acyl-glycerophospholipids by plasmalogenase in different regions of the brain.

Authors:  E M Carey; N M Freeman
Journal:  Neurochem Res       Date:  1983-08       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.